Organigram Holdings Inc. Announces Election of Directors
BAT’s Simon Ashton Appointed to the Board of Directors MONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc….
News
C3 ALERT: Bragar Eagel & Squire, P.C. Is Investigating C3.ai, Inc. on Behalf of C3 Stockholders and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#C3–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is…
International Seaways to Announce Fourth Quarter and Full Year 2021 Results on March 2, 2022
NEW YORK–(BUSINESS WIRE)–International Seaways, Inc. (NYSE: INSW) (the “Company” or “INSW”) announced today that it…
Blue Water Vaccines Announces Closing of Initial Public Offering
CINCINNATI, Feb. 23, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water…
U.S. FDA Licenses Certara’s Immunogenicity Simulator
Affirms the advancements of innovative biosimulation technology and its growing impact in R&D PRINCETON, N.J.,…
New Analysis Published in Peer-reviewed Psychiatry Research Shows Advantages of Combinatorial Algorithm of GeneSight® Psychotropic Test
Analysis shows combinatorial approach is more effective than single-gene testing at predicting sertraline metabolism in patients…
Nephros Announces Fourth Quarter and Fiscal Year 2021 Financial Results
Reports Full-Year Net Revenue of $10.4 Million, a 22% Year-Over-Year Increase and Fourth Quarter Net Revenue…
GBT Reports Fourth Quarter and Full Year 2021 Financial Results
Achieved Oxbryta® (voxelotor) net revenues of $56.1 million in the fourth quarter and $194.7 million…
Vaxcyte Doses First Participants in Phase 1/2 Clinical Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
— Company Expects to Announce Topline Results from the Phase 1/2 Study by the End of…
Orphazyme announces update on regulatory review of arimoclomol in the European Union
Orphazyme A/SCompany announcementNo. 07/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, February 23, 2022 – Orphazyme…
Cytek Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results
2021 Revenue Increased 38% Compared to Prior Year FREMONT, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE)…
Mary Agrotechnologies Inc. Reports First Quarter Fiscal 2022 Financial Results
Markham, Ontario–(Newsfile Corp. – February 23, 2022) – Mary Agrotechnologies Inc. (CSE: MARY) (OTCQB: MRRYF)…
Hyliion Holdings Reports Fourth Quarter and Full Year 2021 Financial Results
AUSTIN, Texas–(BUSINESS WIRE)–Hyliion Holdings Corp. (NYSE: HYLN) (“Hyliion”), a leader in electrified powertrain solutions for…
MVIS Announces February 2022 Monthly Index Review Results of MVIS CryptoCompare Digital Assets Indices
FRANKFURT, Germany–(BUSINESS WIRE)–MV Index Solutions GmbH (MVIS®) today announced the results of the monthly MVIS…
Filing of the 2021 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
Filing of the 2021 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual…
Allogene Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
AlloCAR T™ Studies Resumed and Currently Enrolling Patients Following Removal of Clinical Hold in January…
Personalis to Present at the Cowen 42nd Annual Health Care Conference
MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced…
Insulet Reports Full Year 2021 Revenue Increase of 21% and Fourth Quarter 2021 Revenue Increase of 25% Year-Over-Year
Represents 6th Consecutive Year of Over 20% Revenue Growth; Annual Revenue Surpasses $1 Billion Omnipod…
Perimeter Medical Imaging AI Provides Corporate Update
Live Call/Webcast Today at 5 pm ET TORONTO & DALLAS–(BUSINESS WIRE)–$PINK.V #AI–Perimeter Medical Imaging AI,…
STAAR Surgical Reports Fourth Quarter and Full Year 2021 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of…